These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35949606)

  • 21. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potassium channel-related genes are a novel prognostic signature for the tumor microenvironment of renal clear cell carcinoma.
    Zeng R; Li Y; He DM; Sun MZ; Huang WQ; Wang YH; Zhuo YM; Chen JJ; Chen TH; Guo JH; Huang J
    Front Oncol; 2022; 12():1013324. PubMed ID: 36237326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis.
    Wang S; Wei X; Ji C; Wang Y; Zhang X; Cong R; Song N
    Front Oncol; 2022; 12():781932. PubMed ID: 35356208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and identification of prognostic genes associated with eosinophilic features of clear cell renal cell carcinoma.
    Guo T; Jiang L; Wang T; Zhang J; Liu Y; Wang X; Zhang N; Chen S; Wang X
    Heliyon; 2023 Jun; 9(6):e16479. PubMed ID: 37274638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma.
    Zhang L; Li J; Zhang M; Wang L; Yang T; Shao Q; Liang X; Ma M; Zhang N; Jing M; Song R; Fan J
    Front Genet; 2021; 12():722421. PubMed ID: 34868201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis.
    Zhou L; Ye J; Wen F; Yu H
    Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients.
    Li H; Chen L; Ke ZB; Chen SH; Xue XY; Zheng QS; Wei Y; Zeng K; Xu N
    Int J Gen Med; 2021; 14():6325-6342. PubMed ID: 34629897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
    Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
    BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of candidate biomarker
    Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma.
    Xie M; Lv Y; Liu Z; Zhang J; Liang C; Liao X; Liang R; Lin Y; Li Y
    Cancer Manag Res; 2018; 10():5759-5766. PubMed ID: 30532596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Zheng Y; Wen Y; Cao H; Gu Y; Yan L; Wang Y; Wang L; Zhang L; Shao F
    Onco Targets Ther; 2021; 14():2085-2100. PubMed ID: 33790572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
    Gao X; Yang J; Chen Y
    J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
    Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
    Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
    Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y
    Front Genet; 2021; 12():726369. PubMed ID: 34721523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Analysis of the Butyrate-Metabolism-Related Gene Signature in Tumor Microenvironment-Infiltrating Immune Cells in Clear Cell Renal Cell Carcinoma.
    Tang G; Guan H; Du Z; Yuan W
    Front Cell Dev Biol; 2022; 10():816024. PubMed ID: 35663389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.
    Wang S; Ma X; Ying Y; Sun J; Yang Z; Li J; Jin K; Wang X; Xie B; Zheng X; Liu B; Xie L
    Cancer Cell Int; 2021 Jul; 21(1):341. PubMed ID: 34217271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma.
    Zhang D; Zhang X; Liu Z; Han T; Zhao K; Xu X; Zhang X; Ren X; Qin C
    Front Oncol; 2023; 13():1207068. PubMed ID: 37427103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.